Cunning Capital Partners’s Eli Lilly LLY Stock Holding History

Cunning Capital Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.15M	Hold	2,342	–	–	1.1%	35
2025 Q4	$2.52M	Hold	2,342	–	–	1.16%	29
2025 Q3	$1.79M	Hold	2,342	–	–	0.83%	45
2025 Q2	$1.83M	Hold	2,342	–	–	0.95%	42
2025 Q1	$1.93M	Sell	2,342 -13	-0.6%	-$10.8K	1.23%	37
2024 Q4	$1.82M	Hold	2,355	–	–	1.09%	42
2024 Q3	$2.09M	Hold	2,355	–	–	1.09%	38
2024 Q2	$2.13M	Hold	2,355	–	–	1.19%	27
2024 Q1	$1.83M	Buy	+2,355	New	+$1.68M	1.01%	45

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Cunning Capital Partners's LLY Position: Q1 2026 in Review

Cunning Capital Partners held its Eli Lilly (LLY) position steady in Q1 2026 at 2,342 shares worth $2.15M. The position accounts for 1.1% of the portfolio, ranked #35.

Cunning Capital Partners first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.52M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Cunning Capital Partners held 2,342 shares of Eli Lilly worth $2.15M as of Q1 2026.
Cunning Capital Partners left its Eli Lilly share count unchanged in Q1 2026.
Eli Lilly made up 1.1% of Cunning Capital Partners's portfolio in Q1 2026, its #35 holding.
Cunning Capital Partners first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
Cunning Capital Partners's Eli Lilly position peaked at $2.52M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Cunning Capital Partners's 13F filing for Q1 2026, filed 13 May 2026.